The following is a summary of “Lymphovascular invasion is an independent predictor of metastasis and disease-specific death ...

Compromised antigen presentation ranks among the top mechanisms that render cancers non-immunogenic (non-responsive to immune ...

Neoadjuvant combination immunotherapy may improve survival compared with single-agent therapy for patients with head and neck ...

The precise use of immunotherapy agents in locally advanced head and neck squamous cell carcinoma has not been clearly ...

Summit Therapeutics' ivonescimab shows potential in cancer treatment, but high risks and valuation concerns suggest caution.

Jobevne is a recombinant humanised monoclonal antibody that is used to treat several types of cancer. It is a biosimilar to the reference product Avastine (bevacizumab), Biocon said. Jobevne is a ...

Detecting Early Recurrence With Circulating Tumor DNA in Stage I-III Biliary Tract Cancer After Curative Resection Somatic pathogenic genomic alterations in patients with SCBC, UC, and SCLC of any ...

FIVE-year-old Bonnie Spence has been given less than a year to live after doctors mistook her deadly cancer as a 'broken arm ... that usually helps control cell growth. Who gets it?

Squamous cell carcinoma (SCC) is the main histological subtype in China ... feasibility for the regimen of sintilimab plus chemotherapy in ESCC. This open, single-arm pilot study was performed to ...

INVESTIGATORS AND CLINICIANS anticipate that the next wave of therapeutic approaches in renal cell carcinoma (RCC) will target hypoxia ... In the belzutifan arm, 318 patients (85.5%) discontinued ...

Studies suggest that around 30% of people with tree man syndrome will develop a type of skin cancer called squamous cell carcinoma (SCC). This is the form of cancer that affects squamous cells found ...